Clinical Characteristics of Lymphatic Malformations

Status Completed

Clinical Trial Summary

The primary purpose of this study is to retrospectively identify the clinical characteristics of abdominal lymphatic malformations (ALMs) in our single center in China. The second objective of this study is to retrospectively compare the epidemiological features, clinical presentations, cyst properties, surgical treatments, and risk factors for preoperative complications of ALMs between paediatric participants and adult participants.

Clinical Trial Description

Lymphatic malformations (LMs) are vascular anomalies that arise from abnormal embryonic development of the lymphatic system and can present as dilated lymphatic channels or cysts lined by lymphatic endothelial cells. Abdominal lymphatic malformations (ALMs) are rare entities that account for fewer than 10% of LMs and may occur not only in the tissues or organs in the abdominal cavity, such as the mesentery, spleen and pancreas but also in the retroperitoneal space. ALMs can manifest as an infection, chronic abdominal discomfort, acute abdomen, or fatal disease. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06257719
Study type	Observational
Source	West China Hospital
Contact
Status	Completed
Phase
Start date	January 2009
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04994002` - A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations	Phase 1
Recruiting	`NCT05871970` - Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age	Phase 2
Terminated	`NCT04409145` - First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations	Phase 1/Phase 2
Recruiting	`NCT03972592` - Topical Sirolimus in Cutaneous Lymphatic Malformations	Phase 2
Recruiting	`NCT03243019` - Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations	Phase 2
Recruiting	`NCT02399527` - Lymphatic Anomalies Registry for the Assessment of Outcome Data
Recruiting	`NCT04861064` - Weekly Sirolimus Therapy	Phase 2
Recruiting	`NCT06275022` - A Prospective Study on the Treatment of cLM Based on ICG Imaging	N/A
Recruiting	`NCT05563831` - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Completed	`NCT04836884` - Vascular Anomaly Pathology and Genomics Biopsy Study	N/A
Not yet recruiting	`NCT05983159` - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations	Phase 2